We are live on ! Find out more
IART icon

Integra LifeSciences
IART

249 hedge funds and large institutions have $4.87B invested in Integra LifeSciences in 2018 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 96 increasing their positions, 84 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 84

14% more call options, than puts

Call options by funds: $7.57M | Put options by funds: $6.64M

4.26% more ownership

Funds ownership: 82.58% → 86.85% (+4.3%)

4% more capital invested

Capital invested by funds: $4.67B → $4.87B (+$195M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less funds holding

Funds holding: 257 → 249 (-8)

10% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 40

Holders
249
Holders Change
-8
Holders Change %
-3.11%
% of All Funds
5.69%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
36
Increased
96
Reduced
84
Closed
40
Calls
$7.57M
Puts
$6.64M
Net Calls
+$933K
Net Calls Change
-$658K

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$87.4M
2
Capital World Investors
Capital World Investors
California
+$57.5M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$35.6M
4
Capital Research Global Investors
Capital Research Global Investors
California
+$26.3M
5
First Trust Advisors
First Trust Advisors
Illinois
+$20M

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$46.5M
2
Wells Fargo
Wells Fargo
California
-$33.5M
3
GT
Glenmede Trust
Pennsylvania
-$26.3M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$20.6M
5
Millennium Management
Millennium Management
New York
-$19.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
CII
101
Capital International Inc
California
$2.26M +$1.04M +16,700 +95%
Natixis Advisors
102
Natixis Advisors
Massachusetts
$2.25M +$149K +2,400 +8%
Bessemer Group
103
Bessemer Group
New Jersey
$2.22M -$261K -4,200 -11%
GH
104
GAM Holding
Switzerland
$2.1M – – –
Barclays
105
Barclays
United Kingdom
$1.92M -$3.99M -64,147 -69%
Treasurer of the State of North Carolina
106
Treasurer of the State of North Carolina
North Carolina
$1.92M +$706K +11,368 +64%
TI
107
Trexquant Investment
Connecticut
$1.91M +$1.8M +29,044 New
BCM
108
BlueCrest Capital Management
Jersey
$1.91M -$9.36M -150,671 -84%
OPERF
109
Oregon Public Employees Retirement Fund
Oregon
$1.83M +$1.7M +27,414 +6,993%
T. Rowe Price Associates
110
T. Rowe Price Associates
Maryland
$1.74M -$62 -1 -0%
SOMRS
111
State of Michigan Retirement System
Michigan
$1.72M +$6.21K +100 +0.4%
Federated Hermes
112
Federated Hermes
Pennsylvania
$1.71M -$57.2K -920 -3%
Pacer Advisors
113
Pacer Advisors
Pennsylvania
$1.65M +$171K +2,755 +12%
Nisa Investment Advisors
114
Nisa Investment Advisors
Missouri
$1.62M -$23K -370 -1%
MLICM
115
Metropolitan Life Insurance Company (MetLife)
New York
$1.52M -$14.9K -240 -1%
AIP
116
Ameritas Investment Partners
Nebraska
$1.37M – – –
SG Americas Securities
117
SG Americas Securities
New York
$1.35M -$1.84M -29,630 -59%
CT
118
Cambridge Trust
Massachusetts
$1.34M -$33.2K -534 -3%
VOYA Investment Management
119
VOYA Investment Management
Georgia
$1.33M -$56.5K -909 -4%
LSERS
120
Louisiana State Employees Retirement System
Louisiana
$1.28M +$18.6K +300 +2%
Asset Management One
121
Asset Management One
Japan
$1.25M +$1.2M +19,292 New
AG
122
Aperio Group
California
$1.24M -$108K -1,733 -8%
CCMINC
123
Cardinal Capital Management Inc (North Carolina)
North Carolina
$1.16M +$1.99K +32 +0.2%
WB
124
WesBanco Bank
West Virginia
$1.13M – – –
US Bancorp
125
US Bancorp
Minnesota
$1.12M -$348K -5,605 -25%
3 4
5
6 7

IART Hedge Fund Activity: Q3 2018 in Review

249 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2018, worth a combined $4.87B — up 4.2% from $4.67B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of IART and 36 opened new positions — a net loss of 4 holders — while 84 trimmed existing stakes and 96 added.

The largest buyer was Wellington Management Group, adding an estimated $87.4M. The largest seller was Goldman Sachs, cutting an estimated $46.5M.

  • 249 institutional investors held Integra LifeSciences (IART) as of Q3 2018, down from 257 in Q2 2018.
  • Funds reported $4.87B of Integra LifeSciences stock for Q3 2018, up 4.2% quarter-over-quarter.
  • 36 funds opened new Integra LifeSciences positions in Q3 2018 and 40 closed out, a net change of -4 holders.
  • The largest Integra LifeSciences buyer in Q3 2018 was Wellington Management Group, an estimated $87.4M added.
  • The largest Integra LifeSciences seller in Q3 2018 was Goldman Sachs, an estimated $46.5M sold.

Based on aggregated 13F filings for Q3 2018.